Recent advances in emerging approaches for influenza a detection

Area of Science:

• Virology
• Biomedical Engineering
• Diagnostic Technology

Background:

• Influenza A virus (IAV) poses a significant global public health threat, necessitating improved diagnostic methods.
• Current detection relies on nucleic acid amplification and immunological assays, with limitations in speed and accessibility.
• Advancements are needed for rapid, sensitive, and on-site diagnosis to aid disease control.

Purpose of the Study:

• To review conventional and emerging technologies for influenza A virus detection.
• To explore the integration of traditional methods with modern engineering for enhanced diagnostics.
• To identify challenges and future prospects for translating novel IAV detection platforms into clinical practice.

Main Methods:

• Review of viral nucleic acid amplification techniques.
• Analysis of immunological assays for IAV detection.
• Examination of novel biosensors and point-of-care testing (POCT) devices integrating engineering technologies.

Main Results:

• Conventional methods like nucleic acid amplification and immunoassays are established IAV detection techniques.
• Novel biosensors offer enhanced sensitivity, while POCT devices enable rapid, on-site diagnosis.
• Most advanced platforms are currently in the proof-of-concept stage, primarily validated in laboratory settings.

Conclusions:

• Integration of engineering with IAV detection methods yields promising biosensors and POCT devices.
• Significant challenges remain in validating these novel platforms for widespread clinical application.
• Future research should focus on overcoming these hurdles to facilitate the translation of innovative IAV diagnostics into practice.